Literature DB >> 19693697

Expression, purification and characterization of the extracellular domain of human Flt3 ligand in Escherichia coli.

Xingcheng Zhao1, Ping Zhang, Qiang Liu, Fei He, Lei Feng, Hua Han.   

Abstract

Fms-like tyrosine kinase 3 ligand (Flt3 ligand, FL) is a cytokine that affects the growth, survival and/or differentiation of hematopoietic cells through the activation of specific tyrosine kinase receptors, and is potentially useful for in vitro HSC amplification. To express the extracellular domain of human Flt3 ligand (hFL(ext)) in Escherichia coli, we cloned hFL(ext) and constructed the recombinant expression vector pET32a-hFL(ext). hFL(ext) was successfully expressed in E. coli as a Trx fusion protein (Trx-hFL(ext)) under IPTG (isopropyl-beta-D: -thiogalactopyranoside) induction for 12 h at 30 degrees C. The Trx-hFL(ext) protein, expressed in inclusion bodies even at a low induction temperature, was successfully refolded and purified using dialysis and affinity chromatography. The purified hFL(ext) was biologically active and could effectively stimulate the proliferation of mouse bone marrow nucleated cells revealed by cell proliferation assay and colony forming assay. In addition, in synergize with G-CSF and TPO, recombinant purified hFL(ext) could stimulate ex vivo expansion of murine Lin(-)Sca-1(+)c-Kit(+) cells. Therefore, using the E. coli expression system and an affinity chromatography system, we successfully expressed, refolded, and purified a biologically active Trx-hFL(ext) protein which might be potentially useful for in vitro HSC amplification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19693697     DOI: 10.1007/s11033-009-9724-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

1.  Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells.

Authors:  S D Lyman; L James; T Vanden Bos; P de Vries; K Brasel; B Gliniak; L T Hollingsworth; K S Picha; H J McKenna; R R Splett
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

2.  Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells.

Authors:  S D Lyman; L James; L Johnson; K Brasel; P de Vries; S S Escobar; H Downey; R R Splett; M P Beckmann; H J McKenna
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

3.  Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.

Authors:  S Fukuda; L M Pelus
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

4.  Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells.

Authors:  H E Broxmeyer; L Lu; S Cooper; L Ruggieri; Z H Li; S D Lyman
Journal:  Exp Hematol       Date:  1995-09       Impact factor: 3.084

Review 5.  FLT3: receptor and ligand.

Authors:  Hans G Drexler; Hilmar Quentmeier
Journal:  Growth Factors       Date:  2004-06       Impact factor: 2.511

6.  Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: utilization for ovarian cancer treatment.

Authors:  Noriomi Matsumura; Masaki Mandai; Junzo Hamanishi; Ken Yamaguchi; Ken Fukuhara; Haruhiko Yagi; Toshihiro Higuchi; Kenji Takakura; Shingo Fujii
Journal:  Oncol Rep       Date:  2008-02       Impact factor: 3.906

7.  Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs.

Authors:  S D Lyman; L James; S Escobar; H Downey; P de Vries; K Brasel; K Stocking; M P Beckmann; N G Copeland; L S Cleveland
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

8.  Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.

Authors:  C Hannum; J Culpepper; D Campbell; T McClanahan; S Zurawski; J F Bazan; R Kastelein; S Hudak; J Wagner; J Mattson
Journal:  Nature       Date:  1994-04-14       Impact factor: 49.962

9.  The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.

Authors:  L S Rusten; S D Lyman; O P Veiby; S E Jacobsen
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

10.  Flt3-L gene therapy enhances immunocytokine-mediated antitumor effects and induces long-term memory.

Authors:  Zane C Neal; Paul M Sondel; Mary Kay Bates; Stephen D Gillies; Hans Herweijer
Journal:  Cancer Immunol Immunother       Date:  2007-04-11       Impact factor: 6.968

View more
  2 in total

1.  Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1.

Authors:  Sirisha Potala; Rama S Verma
Journal:  Mol Biol Rep       Date:  2010-08-01       Impact factor: 2.316

2.  Site-specific N-linked glycosylation of receptor guanylyl cyclase C regulates ligand binding, ligand-mediated activation and interaction with vesicular integral membrane protein 36, VIP36.

Authors:  Najla Arshad; Suhas Ballal; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2012-12-26       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.